Suicidal erythrocyte death in end-stage renal disease

Journal of Molecular Medicine

Volumn 92, Issue 8, 2014, Pages 871-879

  Abed, Majed ^a   Artunc, Ferruh ^a   Alzoubi, Kousi ^a   Honisch, Sabina ^a   Baumann, Dorothea ^a   Föller, Michael ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anemia; Calcium; Ceramide abundance; Dialysis; End stage renal disease; Eryptosis; Oxidative stress; Phosphatidylserine

Indexed keywords

ANTIBODY CONJUGATE; CALCIUM ION; CERAMIDE; DICHLORODIHYDROFLUORESCEIN; ISOTHIOCYANIC ACID; LIPOCORTIN 5; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; CALCIUM;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL VOLUME; CLINICAL ARTICLE; CONFOCAL LASER SCANNING MICROSCOPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; END STAGE RENAL DISEASE; ERYTHROCYTE MEMBRANE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMODIALYSIS; HUMAN; IMMUNOFLUORESCENCE; MALE; OXIDATIVE STRESS; UREMIA; VERY ELDERLY; APOPTOSIS; BIOSYNTHESIS; CASE CONTROL STUDY; DRUG EFFECTS; ERYTHROCYTE; INTRACELLULAR SPACE; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A5; APOPTOSIS; CALCIUM; CASE-CONTROL STUDIES; CELL DEATH; CERAMIDES; ERYTHROCYTES; FEMALE; HUMANS; INTRACELLULAR SPACE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES;

EID: 84906791224     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1151-4     Document Type: Article

References (40)

1. Yang M, Fox CH, Vassalotti J, Choi M (2011) Complications of progression of CKD. Adv Chronic Kidney Dis 18:400-405
2. Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, Goldsmith D (2013) Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol 14:24
3. Atkinson MA, Furth SL (2011) Anemia in children with chronic kidney disease. Nat Rev Nephrol 7:635-641
4. Parfrey PS (2011) Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure. Curr Opin Nephrol Hypertens 20:177-181
5. Fishbane S, Nissenson AR (2010) Anemia management in chronic kidney disease. Kidney Int Suppl 10.1038/ki.2010.188: S3-9
6. Adamson JW (2009) Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation. Adv Chron Kidney Dis 16:76-82
7. Besarab A, Frinak S, Yee J (2009) What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway? Adv Chron Kidney Dis 16:131-142
8. Macdougall IC, Ashenden M (2009) Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications. Adv Chron Kidney Dis 16:117-130
9. Wish JB (2009) Past, present, and future of chronic kidney disease anemia management in the United States. Adv Chron Kidney Dis 16: 101-108
10. Yee J, Zasuwa G, Frinak S, Besarab A (2009) Hemoglobin variability and hyporesponsiveness: much ado about something or nothing? Adv Chron Kidney Dis 16:83-93
11. Artunc F, Risler T (2007) Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrol Dial Transplant 22:2900-2908 (Pubitemid 350093434)
12. Attanasio P, Ronco C, Anker SD, Cicoira M, von Haehling S (2012) Role of iron deficiency and anemia in cardio-renal syndromes. Semin Nephrol 32:57-62
13. Besarab A, Coyne DW (2010) Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 6:699-710
14. Kwack C, Balakrishnan VS (2006) Managing erythropoietin hyporesponsiveness. Semin Dial 19:146-151 (Pubitemid 43468648)
15. Kovesdy CP (2009) Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients. Adv Chron Kidney Dis 16:109-116
16. Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ (2011) Red blood cell survival in long-term dialysis patients. Am J Kidney Dis 58:591-598
17. Lang E, Qadri SM, Lang F (2012) Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 44:1236-1243
18. Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C, Kaestner L, Bernhardt I (2011) Regulation of phosphatidylserine exposure in red blood cells. Cell Physiol Biochem 28:847-856
19. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F (2003) Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 14:2750-2757 (Pubitemid 37305637)
20. Popolo A, Autore G, Pinto A, Marzocco S (2013) Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radic Res 47:346-356
21. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP, Kong SK (2012) In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 6:847-856
22. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, Ciccoli L (2013) Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 50:489-495
23. Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V, Zbidah M, Plate A, Bitzer M, Foller M et al (2012) Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 30:876-888
24. Shaik N, Lupescu A, Lang F (2012) Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 30:512-522
25. Ahmed M, Langer H, Abed M, Voelkl J, Lang F (2013) The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 37:158-167
26. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F (2014) Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 38:42-51
27. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, Lang F (2012) Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res 36:107-118
28. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C, Towhid ST, Lang F (2013) Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 37:567-578
29. Abed M, Herrmann T, Alzoubi K, Pakladok T, Lang F (2013) Tannic acid induced suicidal erythrocyte death. Cell Physiol Biochem 32:1106-1116
30. Bissinger R, Modicano P, Frauenfeld L, Lang E, Jacobi J, Faggio C, Lang F (2013) Estramustine-induced suicidal erythrocyte death. Cell Physiol Biochem 32:1426-1436
31. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M, Koberle M, Lang E, Dreischer P, Biedermann T, Duszenko M, Lang F et al (2013) Age sensitivity of NFkappaB abundance and programmed cell death in erythrocytes induced by NFkappaB inhibitors. Cell Physiol Biochem 32:801-813
32. Jilani K, Qadri SM, Lang F (2013) Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 32:1600-1609
33. Lupescu A, Jilani K, Zbidah M, Lang F (2013) Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 32:291-299
34. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M, Gawaz M, Lang F (2012) Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 302:C644-C651
35. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B et al (2006) Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 84:378-388 (Pubitemid 43673612)
36. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V et al (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153:23-33
37. Staude H, Jeske S, Schmitz K, Warncke G, Fischer DC (2013) Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease. Kidney Blood Press Res 37:68-83
38. Foller M, Kasinathan RS, Koka S, Huber SM, Schuler B, Vogel J, Gassmann M, Lang F (2007) Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin. Am J Physiol Regul Integr Comp Physiol 293:R1127-R1134 (Pubitemid 47358933)
39. Singh AK (2010) What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? Curr Opin Nephrol Hypertens 19:420-424
40. Elliott J, Mishler D, Agarwal R (2009) Hyporesponsiveness to erythropoietin: causes and management. Adv Chron Kidney Dis 16:94-100